Our results support the notion that lower HCaRG expression observed in ccRCC may contribute to tumor-associated sustained proliferative phenotypes and neovasculature, thus resulting in rapid tumor progression (Figure 7). The gene discussed is COMMD5; the disease is nonpapillary renal cell carcinoma.